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Flavonoid, symbolize an extraordinary assembly of plant secondary metabolites, in 
addition new investigations suggest as a traditional medicines, with therapeutic impact. 
Flavonoid molecules encompass characteristic structures diversity and wide-ranging 
pharmacological activities that may afford new drug discovery with inventive and 
prospective therapeutic indications to cancer chemoprevention and chemotherapy. Recent 
research background enhances predominantly functional activity of Flavonoids for cancer 
research. In this review we make sure about Flavonoid with all prospective of their anti-
cancerous property.   
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A human adult comprises about 1015 cells; scores of them divide and differentiate in 
order to refurbish organs and tissues, which require cell turnover 1. However, if the cells do not 
stop dividing, they may lead to cancer. Characteristically, cancer is an unrestrained 
proliferation of cells which become structurally abnormal and possess the ability to detach them 
from a tumor and establish a new tumor at a remote site within the host2. Globally, cancer 
represents a substantial burden of disease in the community and appears to be a prime cause of 
concern. Every year over 200,000 people are diagnosed with cancer in the United Kingdom 
only, and approximately 120,000 die as an aftermath of the disease3. According to the 
International Agency for Research on Cancer, in 2002, cancer killed > 6.7 million people around 
the world and another 10.9 million new cases were diagnosed4. If the results are extrapolated, at 
the same rate, an estimated 15 million people will have cancer, annually, by 2020.  According to 
an estimate given by American Cancer Society5, about 1,500,000 new cases and over 500,000 
deaths are expected in the US by 2009. The National Cancer Registry of South Africa has spotted 
the cancers of bladder, colon, breast, cervix, lungs and melanoma commonly among 
inhabitants6. Attempts are underway to work out the therapeutic and anti-neoplastic properties 
of medicinal plants7-12. Plant bioactive compound is a potential source for antitumor and 
cytotoxic activities13-14. Consequently, herbal medicines have received much attention as 
substitute anticancer drugs.  
 
FLAVONOIDS 
Flavonoids are  compounds form one of the key classes of derivative metabolites; they exhibit a 
variety of structures and are responsible for the major characteristics properties. Flavonoids are 
well conventional that plants have constantly been valuable sources of antitumor or cancer 
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obstacle compounds15-16. Huge groups of different phenolic compounds from plants are 
significant and vital anticancer agents17- 18. In numerous cases, they are much more successful 
and In fact, they are much studied in order to discover their additional use in pharmacy and 
medicine in the prevention and therapeutic of cancer.  
 
STRUCTURE OF FLAVONOID MOLECULE 
Flavonoids are a group of more than 4000 polyphenolic compounds that occur in nature in 
plant foundation. These compounds acquire a common phenyl-benzopyrone arrangement (C6-
C3-C6), and they are categorized according to the saturation level and opening of the 
fundamental pyran ring, mainly into flavones, flavanols, isoflavones, flavonols, flavanones, and 
flavanonols. 
 
 
 
Fig.1 Basic structure of flavonoid molecule 
Modification of the 'C' and 'B' give rise to an array of flavonoids: 
Flavanone, R3-H, R4=O, R1-H, R2-H 
Dihydroflavonol, R3-OH, R4=O, R1-H, R2-H  
Leucoanthocyanidin, R3-OH, R4-OH, R1-H, R2-H 
Anthocyanidin, R3-OH, R4-H, O1 =C2, C3=C4, R1-H, R2-H  
Anthocyanin, R3-OGLC, R4-H, O1=C2, C3=C4 R1-H, R2-H 
Flavone, R3-H, R4=O, C2=C3, R1-H, R2-H  
Isoflavanone, shift of aryl group (B ring) from C2 to C3 position 
Flavonol, R3-OH, R4=O, C2=C3, R1-H, R2-H 
Monohydroxyl flavonoid (e.g., pelargonin), R1-H, R2-H 
Dihydroxyl flavonoid (e.g., cyanin), R1-OH, R2-H 
Trihydroxyl flavonoid (e.g., delphinin), R1-OH, R2-OH 
FLAVONOIDS: BIOLOGICALLY ACTIVE COMPOUNDS  
In recent years, researches about flavonoids are becoming the area under discussion of 
therapeutic research and flavonoids represent one of the most interesting groups of biologically 
active compounds. flavonoids compounds have an amazing variety of biological activity lying 
on cancer prevention. These comprise, for instance, antimutagenic, and anti-carcinogenic, 
activities 19-21. In addition majority of flavonoids have been definite to inhibit many kinds of 
cultured human cancer cell lines, at the same time as less or no toxic to human typical cells22-26. 
Flavonoids are concerned in the regulation of cell proliferation and anticancer properties23, 24, 27-
31. Flavonoids have been shown as angiogenesis inhibitors derived from natural sources32. 
Therefore, flavonoids compounds may have potential in support of the cure of solid tumors33-34. 
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FLAVONOIDS AND CANCER PREVENTION 
Dietary flavonoids, combined with other components such as various vitamins, play an 
important role in cancer prevention. Flavonoids act on reactive oxygen species, cell signal 
transduction pathways related to cellular proliferation, apoptosis, and angiogenesis. It has been 
stated that flavonoids, as antioxidants, can inhibit carcinogenesis35. Some flavonoids- such as 
fisetin, apigenin, and luteolin are stated to be potent inhibitors of cell proliferation36. However 
there have been a number of reports that directly contradict the potential role of flavonoids as 
antioxidants/anticancer agents. Up to that time published relevant literature for protection 
against some forms of cancer has shown many common flavonoids such as the synthetic 
flavone, flavopiridol, soy isoflavonoid- Genistein, and many researchers have tried to elucidate 
possible structural activity relationships that might lead to new drug discovery and focuses on 
the biological effects of the main flavonoids, Overall, exciting data show that dietary flavonoids 
could be considered as a useful cancer preventive approach. 
 
DRUG DISCOVERY  
Current research reveals the different potential application of flavonoids for control disease. 
Drug development is essential part of research on dietary flavonoids compounds that showed 
improved drug-like properties. We highlight the role of Ethno-medicine and its assessment in 
favor of drug discovery. In the present time herbal products are considered to be symbols of 
protection in comparison  to the synthetic product that are regarded as unsafe to human life and 
environment. 
 
CONCLUSION 
Although a large number of synthetic drugs are being added to the world of modern 
pharmacopoeia, but still no system of medicine in the world which can solve all the health 
problems. Therefore the search for new therapeutic constituents from plants is genuine and 
urgent. There are large numbers of indigenous plants left which have not been investigated 
thoroughly from modern scientific view or their curative values have not been recognized. Thus 
there is an urgent need for systematic phytochemical investigation of those plants which have 
not been investigated systematically or worked at a time when modern facilities were not 
available for their potential therapeutic components. More research can be done to investigate 
the unknown and unexplored potential of plants flavonoids. Further analysis of flavonoids can 
be carried out by way of making use of different analytical methods such as HPTLC, HPLC, 
FTIR, NMR and UV spectrophotometer analysis. 
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